Hrs Investment Holdings, LLC Abb Vie Inc. Transaction History

Hrs Investment Holdings, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.51 Million - $2.95 Million	-32,500 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $2.14 Million - $2.64 Million	-27,500 Reduced 45.83%	32,500 $3 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $1.61 Million - $2.16 Million	17,500 Added 41.18%	60,000 $5.68 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $223,900 - $245,524	-2,500 Reduced 5.56%	42,500 $4.11 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $3.14 Million - $4.01 Million	45,000	45,000 $4 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hrs Investment Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Hrs Investment Holdings, LLC with notifications on news.